COST EFFECTIVENESS ANALYSIS COMPARING ENZALUTAMIDE, ABIRATERONE PLUS PREDNISONE AND CABAZITAXEL PLUS PREDINSONE FOR THE TREATMENT OF VISCERAL METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) POST DOCETAXEL FAILURE
被引:0
作者:
Barqawi, Y.
论文数: 0引用数: 0
h-index: 0
机构:
Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USAUniv New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
Barqawi, Y.
[1
]
Borrego, M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USAUniv New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
Borrego, M.
[1
]
Roberts, M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USAUniv New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
Roberts, M.
[1
]
Abraham, I
论文数: 0引用数: 0
h-index: 0
机构:
Univ Arizona, Coll Pharm, Ctr Hlth Outcomes & PharmacoEcon Res, Tucson, AZ 85721 USAUniv New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
Abraham, I
[2
]
机构:
[1] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
[2] Univ Arizona, Coll Pharm, Ctr Hlth Outcomes & PharmacoEcon Res, Tucson, AZ 85721 USA